270
Views
14
CrossRef citations to date
0
Altmetric
Original Article

Cost-effectiveness comparison of current proton-pump inhibitors to treat gastro-oesophageal reflux disease in the UK

, , &
Pages 1505-1517 | Accepted 03 Aug 2005, Published online: 26 Aug 2005

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (2)

Stefano Pallotta, Fabio Pace & Silvia Marelli. (2008) Rabeprazole: a second-generation proton pump inhibitor in the treatment of acid-related disease. Expert Review of Gastroenterology & Hepatology 2:4, pages 509-522.
Read now
Fabio Pace, Stefano Pallotta, Stefania Casalini & Gabriele Bianchi Porro. (2007) A review of rabeprazole in the treatment of acid-related diseases. Therapeutics and Clinical Risk Management 3:3, pages 363-379.
Read now

Articles from other publishers (12)

Martti Kulvik, Raine Hermans, Ismo Linnosmaa & Joel Shalowitz. (2015) An economic model to assess the cost-benefit of BNCT. Applied Radiation and Isotopes 106, pages 3-9.
Crossref
Andrew J. Gawron, Joseph Feinglass, John E. Pandolfino, Bruce K. Tan, Michiel J. Bove & Stephanie Shintani-Smith. (2015) Brand Name and Generic Proton Pump Inhibitor Prescriptions in the United States: Insights from the National Ambulatory Medical Care Survey (2006–2010). Gastroenterology Research and Practice 2015, pages 1-7.
Crossref
Andrew J. Gawron, Dustin D. French, John E. Pandolfino & Colin W. Howden. (2014) Economic Evaluations of Gastroesophageal Reflux Disease Medical Management. PharmacoEconomics 32:8, pages 745-758.
Crossref
Steven Simoens. (2011) Public health and prevention in Europe: is it cost-effective?. Journal of Pharmaceutical Health Services Research 2:3, pages 151-155.
Crossref
Doo Hyun Nam, So Young Park, Jong Min Park & Sung Chull Kim. (2011) Therapeutic and cost effectiveness of proton pump inhibitor regimens for idiopathic or drug-induced peptic ulcer complication. Archives of Pharmacal Research 34:3, pages 443-449.
Crossref
Naoki Chiba & M Brian Fennerty. 2010. Evidence‐Based Gastroenterology and Hepatology. Evidence‐Based Gastroenterology and Hepatology 17 61 .
Stéphane Mouly, Agnès Charlemagne, Philippe Lejeunne & Francis Fagnani. (2009) Therapeutic management of uncomplicated gastroesophageal reflux disease in france in 2005: Potential cost savings of omeprazole substitution. Current Therapeutic Research 70:4, pages 282-298.
Crossref
Claudine M. Baldwin & Susan J. Keam. (2009) Rabeprazole. Drugs 69:10, pages 1373-1401.
Crossref
Joel J. Heidelbaugh, Kathleen L. Goldberg & John M. Inadomi. (2009) Overutilization of Proton Pump Inhibitors. American Journal of Gastroenterology 104, pages S27-S32.
Crossref
Joel J Heidelbaugh, Kathleen L Goldberg & John M Inadomi. (2009) Overutilization of Proton Pump Inhibitors: A Review of Cost-Effectiveness and Risk in PPI. The American Journal of Gastroenterology 104:S2, pages S27-S32.
Crossref
David C Metz, John M Inadomi, Colin W Howden, Sander J Veldhuyzen van Zanten & Peter Bytzer. (2007) On-Demand Therapy for Gastroesophageal Reflux Disease. The American Journal of Gastroenterology 102:3, pages 642-653.
Crossref
Full-Young Chang. (2006) Medical economy and acid reflux diseases. Journal of Gastroenterology and Hepatology 21:s5, pages S129-S132.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.